The world class expertise of the Health Protection Agency's Biopharmaceutical Production Unit aids the development of new vaccines, therapeutic proteins and enzyme products, assisting biotechnology companies in the challenging process of taking an original concept from the bench through to the production of GMP biopharmaceutical material for clinical trials.
Download the Health Protection Agency's new, free whitepaper to find out more. Click here to download.
Twitter